A single OASIS assessment can run past 100 items, and home health nurses have said for years that clicking through it takes longer than writing it by hand ever did. In 2026, a wave of AI scribes — Enzo Health, SOAP Note Buddy, and Copper Digital among them — are selling a fix, each with a different mechanism and a different price tag. Finding the best AI scribe for home health agencies means weighing speed against OASIS accuracy and who’s ultimately liable if the chart is wrong.

The stakes go beyond time saved. Whatever the AI drafts, the visiting clinician signs the OASIS assessment, and CMS audits the person who signed — not the software that helped write it. OASIS-E2 takes effect for all assessments dated on or after April 1, 2026, per CMS, which means the item set is changing at the exact moment agencies are handing more of the drafting to AI.

The short version: SOAP Note Buddy is the lowest-risk, lowest-cost entry point for a solo clinician or small agency testing whether AI-assisted charting actually helps. Copper Digital is built specifically around OASIS accuracy and prices per assessment, making it the more defensible pick at agency scale. Enzo Health has the boldest numbers in its marketing — and the least independent evidence behind them.

Why OASIS documentation is the burnout point, not just an annoyance

OASIS — the Outcome and Assessment Information Set — is the CMS-mandated assessment home health clinicians complete at start of care, resumption of care, recertification, transfer, and discharge. It is also, by a wide margin, the most-complained-about part of the home health nursing job.

“I find some of Oasis takes me longer to chart than paper,” one nurse wrote on r/nursing. “Mouse to page click click click repeat repeat repeat. I could have done that on paper much quicker. And OASIS doesn’t learn. If he didn’t have legs when I got him, he’s not going to have them on subsequent visits.”

The complaint isn’t that documentation exists. It’s that OASIS repeats dozens of near-identical fields per visit without absorbing what the clinician already established. A different nurse, describing home health workload specifically, framed the compounding effect this way: “I hated the Oasis charting, its redundant. The being on call, getting your own auths… They definitely found the way to make home health 100% harder.”

That is the exact opening AI scribe vendors are building products into. Nurses on r/nursing have already anticipated the shift in plain terms: “Pretty soon we are going to have our own scribes to follow us and chart for us,” one wrote — a prediction from inside a documentation-burden thread, not a product review.

The underlying economics explain why vendors are moving fast. Home health referral volume keeps growing while the clinician workforce doesn’t, and every hour spent on OASIS is an hour not spent on a visit. That is the real addressable problem for AI in home health — not diagnosis, not clinical decision-making. Paperwork.

Best AI Scribe for Home Health Agencies: Enzo Health vs. SOAP Note Buddy vs. Copper Voice at a Glance

For clinicians working outside home health, best AI medical scribes overall and AI scribes built for nurse practitioners cover the broader outpatient market these three products don’t target.

Enzo Health (Enzo Scribe): the boldest numbers, the least independent verification

Enzo Health markets Enzo Scribe on aggressive claims: documentation completed 75% faster, 95%-plus accuracy, and an average revenue capture increase of $185 per episode. Every one of those figures is vendor self-reported. None of them appears in an independent audit, a peer-reviewed evaluation, or a third-party benchmark — they come from Enzo’s own marketing materials.

The company’s funding is real and verifiable. Enzo Health announced a $26 million raise via a PRNewswire release, citing “unprecedented nationwide demand for post-acute care” as the driver behind the expansion. That level of capital signals a company built for scale, and it is a meaningfully larger raise than either competitor discloses.

What’s missing is a community track record. No independent Reddit threads, App Store reviews, or clinician forum posts turned up describing hands-on Enzo Scribe experience — a transparency gap worth flagging directly rather than papering over. Its pricing is also not public; the sales process is gated, which makes it harder for a small agency to compare Enzo against a published-price competitor without a demo call first.

None of this means the product doesn’t work. It means the agency buying it is trusting the vendor’s own numbers, not a third party’s, and should ask for verifiable pilot data — not just a sales deck — before signing.

SOAP Note Buddy: no ambient recording, no consent hurdle

SOAP Note Buddy takes a different approach than ambient listening: the clinician drives input through voice-to-text and structured templates rather than the app passively recording the visit. That distinction matters operationally. Home health visits happen inside patients’ private homes, and consent-to-record requirements vary by state — an ambient scribe has to solve that conversation every visit. SOAP Note Buddy sidesteps it by design.

Pricing is published and simple: it starts at $29 per month with a 7-day free trial, and every tier includes unlimited patients. Higher tiers exist for clinicians who want more — a roughly $59-per-month plan bundles the standalone voice app with a Chrome extension for charting inside a browser-based EHR (soapnotebuddy.com pricing page, checked September 2026). There’s no contract negotiation and no sales call required to see the price.

The App Store reviews back a specific, repeated theme: time recovered, not just typing reduced. “This product is wonderful and the creator is always helpful as a fellow clinician!” one reviewer wrote. “This app has allowed me to effectively perform my actual job as a PT vs a ‘skilled data entry person.’” Another described the effect on work-life balance directly: “Soap note buddy has brought a work life balance back into my life. I can finally be done with my notes during the work day and I never have to bring them home! I have my weekends back!”

That “creator is a fellow clinician” detail also signals a smaller, founder-led product — a contrast to Enzo’s $26 million raise and undisclosed team scale. Smaller doesn’t mean worse here; it means a lower-stakes, lower-commitment way to test whether AI-assisted charting changes anything before an agency commits budget at scale.

Copper Digital (Copper Voice): the OASIS-specific QA play, priced for agencies

Copper Digital prices differently than either competitor: per-assessment and per-visit rather than a flat monthly seat. OASIS SOC assessments run $20 each, routine visit notes run $4 each, and there’s a $35-per-patient monthly component — combining to roughly $1,200 per month starting for a 300-census agency (copperdigital.com pricing page). That structure scales directly with census and visit volume, which makes cost comparisons against SOAP Note Buddy’s flat tiers dependent entirely on an agency’s size.

Copper markets itself around OASIS QA specifically — catching item-level errors before submission rather than just generating a faster first draft. The company’s own claims put documentation completion under 10 minutes and 20 minutes saved per note. As with Enzo’s figures, these are vendor-reported numbers, not third-party validated ones, and should be treated as marketing claims rather than established fact.

As with Enzo, no independent Reddit threads or App Store reviews of Copper Voice or Copper Digital turned up in a community search. That’s a second data point in the same direction: the two products with the most aggressive time-savings claims are also the two with no visible independent user commentary to check those claims against. Agencies evaluating Copper should ask for reference customers directly rather than relying on the published figures alone.

PT-heavy home health agencies weighing Copper against a dedicated monitoring stack, rather than just documentation, can also compare RTM software for home-based PT practices.

Who actually owns the OASIS chart? Clinician liability and CMS audit risk

This is the differentiator that matters more than any speed claim. CMS requires the assessing clinician to review and sign the OASIS assessment personally — the AI draft is an input, not a submission. Vendor terms of service across AI scribe products, as is standard in the category, disclaim liability for the accuracy of AI-generated content. The responsibility to verify sits with the signing clinician, contractually and legally, regardless of which tool drafted the note.

That responsibility just got heavier. OASIS-E2 takes effect for all assessments — start of care, resumption of care, recertification, transfer, and discharge — dated on or after April 1, 2026, per CMS’s OASIS Data Sets and OASIS-E2 change table. A0810 (Sex) replaces the former M0069 (Gender) item. A1250 (Transportation) replaces A1255. The O0350 COVID-19 vaccination item is removed entirely.

Any AI scribe tuned on the old item set carries fresh error risk at the exact rollout window — autofill logic built around retired fields doesn’t magically update itself. A scribe that saves time on the old OASIS-E1 form is not automatically accurate on OASIS-E2. Agencies adopting any of these three tools around the April 2026 transition should treat every AI-drafted item as a first read, not a final one, until the new item mappings are confirmed against a live CMS-published note.

Does an AI scribe reduce nurse turnover, or just shift the burden?

A useful data point comes from outside all three products under review. Andy AI, a comparable AI charting tool used in home-health-adjacent physical therapy, drew this assessment on r/physicaltherapy: “Been using Andy for about 6 months now and it’s pretty solid honestly. Still gotta edit stuff but way less than I expected — maybe like 20% of the note instead of writing the whole thing from scratch. For OASIS it’s decent but not perfect, you’ll definitely need to double check those since they’re so important for reimbursement. Works fine in homes though, just need decent cell signal.”

Two things stand out. First, even a satisfied long-term user still edits roughly a fifth of every note — the AI compresses drafting time, it doesn’t eliminate review. Second, the same user explicitly singles out OASIS items for extra scrutiny because of reimbursement stakes, which lines up directly with the CMS audit-risk point above.

Turnover in home health is driven by more than documentation speed. The same nurse who called OASIS charting redundant also named the structural load underneath it: “The being on call, getting your own auths… They definitely found the way to make home health 100% harder.” An AI scribe addresses the documentation slice of that stack. It does nothing for on-call rotation, prior-auth chasing, or caseload size — the factors more directly tied to burnout research in home health nursing.

EHR integration: Axxess, WellSky, Homecare Homebase, Kinnser

Fragmentation is the underlying complaint behind most of this. As one nurse put it on r/nursing, describing an attempt to build documentation software: “I’m actually working on a software to help with documentation and discharging but there’s too many companies with different EHRs and a lot of it is outdated already.” That fragmentation is exactly what determines whether any of these three tools fits a given agency.

SOAP Note Buddy positions itself as EHR-agnostic — auto-fill designed to work regardless of whether the agency runs Axxess, Homecare Homebase, or Kinnser, since the clinician is driving the input rather than the software integrating at the API level. Copper works alongside the existing EMR rather than inside it. Enzo markets itself as “EHR-ready” without naming which integrations are actually live, which is worth confirming directly with sales before assuming compatibility.

Agencies already on WellSky Home Health EHR have a fourth, easy-to-overlook option: WellSky Scribe, part of the SkySense AI suite, included at no extra cost for existing WellSky Home Health clients (BusinessWire, October 2025). WellSky’s own figure is up to a 50% reduction in documentation time — a vendor claim, same caveat as the others, but one that comes with zero incremental cost for agencies already paying for the EHR. Any agency on WellSky should check that native option before buying a third-party tool that has to bolt on separately.

For clinicians splitting time between home health and outpatient dictation, general-purpose ambient scribes like Suki and Nuance DAX Copilot target broader dictation rather than OASIS specifically, and are worth a separate look for the non-home-health side of a mixed caseload.

The Best AI Scribe for Home Health Agencies: Our Pick

Pick Enzo Health if the agency has enough OASIS volume to run its own validation pilot and can insist on verifiable accuracy data rather than accepting the marketing figures as-is. The $26 million raise suggests staying power. The 75% faster and 95%-plus accuracy numbers are Enzo’s own, not third-party audited, and the pricing stays behind a sales call.

Pick SOAP Note Buddy if the buyer is a solo clinician, small agency, or PT/OT/SLP group that wants to test AI-assisted charting without a sales call, a contract negotiation, or a consent-to-record conversation with patients. At $29 a month with a 7-day trial, the downside of trying it is small, and the published price makes budgeting straightforward.

Pick Copper Digital if OASIS accuracy and QA review time is the actual bottleneck rather than raw drafting speed, and the census is large enough that per-assessment pricing — roughly $1,200 a month starting for 300 patients — competes favorably against the labor cost of manual chart review.

Whichever tool an agency lands on, the clinician’s signature remains the last line of defense. None of these products changes who CMS holds accountable when an assessment is wrong.

Agencies layering documentation AI into a broader home-health tech stack can also review remote patient monitoring software for independent practices as a parallel investment.

Frequently Asked Questions

Does an AI scribe replace the OASIS assessment itself?

No. All three tools draft or assist the note; CMS requires the assessing clinician to complete, review, and sign the OASIS assessment personally. The AI output is an input to that process, not a substitute for it.

Is it safe to use ambient AI recording during home health visits?

It depends on state consent-to-record laws, which vary and apply inside a patient’s home the same as anywhere else. SOAP Note Buddy avoids this question by not recording ambiently; Enzo and Copper’s ambient or voice-capture features require agencies to confirm consent procedures in every state they operate.

How does OASIS-E2 change what these tools need to capture starting April 2026?

OASIS-E2 replaces M0069 (Gender) with A0810 (Sex), replaces A1250 (Transportation) with A1255, and removes the O0350 COVID-19 vaccination item, per CMS. Any AI scribe not updated for the new item set risks misfiling data on assessments dated on or after April 1, 2026.

Can these tools work with agencies still on Kinnser or Homecare Homebase?

SOAP Note Buddy is positioned as EHR-agnostic and designed to auto-fill regardless of the underlying system. Copper works alongside an existing EMR rather than inside it. Enzo’s specific integrations aren’t publicly listed — confirm compatibility directly with sales before assuming it works with a given EHR.

Do these AI scribes lower liability risk for the clinician who signs?

No. Vendor terms of service in this category consistently disclaim liability for AI-generated content accuracy, and CMS audits the signing clinician, not the software vendor. An AI scribe can reduce drafting time; it does not reduce the clinician’s review obligation.

The bottom line on AI and OASIS documentation

SOAP Note Buddy is the lowest-risk way for a solo clinician or small agency to test AI-assisted OASIS charting, at a published $29 a month. Copper Digital is the stronger fit once OASIS QA accuracy, not typing speed, is the actual cost center, provided the agency’s census justifies its per-assessment pricing. Enzo Health has the best funding and the boldest marketing numbers, and the least independent evidence to back them — a gap worth pushing on before signing.

AI can shorten the time it takes to write the OASIS assessment. It cannot shorten the time it takes to be right about it — and CMS only audits the person who signed.